NCT00150423View on ClinicalTrials.gov

To Evaluate the Safety and Efficacy of Pregabalin in Patients With Painful Diabetic Peripheral Neuropathy.

PHASE3CompletedINTERVENTIONAL
Enrollment

384

Participants

Timeline

Start Date

January 31, 2001

Study Completion Date

July 31, 2005

Conditions
Diabetic Neuropathy, Painful
Interventions
DRUG

Pregabalin

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY